| modified amino acid transport | GO:0072337 | 11 | 1.000 | |
| negative regulation of phosphatidylinositol 3 kinase signaling | GO:0014067 | 4 | 0.998 | |
| adenylate cyclase activating dopamine receptor signaling pathway | GO:0007191 | 3 | 0.991 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 43 | 0.983 | |
| amino acid betaine transport | GO:0015838 | 4 | 0.938 | |
| negative regulation of platelet derived growth factor receptor signaling pathway | GO:0010642 | 4 | 0.908 | |
| regulation of cyclase activity | GO:0031279 | 19 | 0.903 | |
| phospholipase c activating dopamine receptor signaling pathway | GO:0060158 | 2 | 0.901 | |
| renal sodium ion transport | GO:0003096 | 2 | 0.883 | |
| activation of mapk activity by adrenergic receptor signaling pathway | GO:0071883 | 3 | 0.818 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 60 | 0.809 | |
| regulation of cgmp metabolic process | GO:0030823 | 9 | 0.809 | |
| regulation of guanylate cyclase activity | GO:0031282 | 2 | 0.797 | |
| sodium ion homeostasis | GO:0055078 | 14 | 0.796 | |
| inner ear morphogenesis | GO:0042472 | 4 | 0.721 | |
| negative regulation of cgmp metabolic process | GO:0030824 | 1 | 0.708 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 61 | 0.701 | |
| hair cell differentiation | GO:0035315 | 2 | 0.678 | |
| renal absorption | GO:0070293 | 6 | 0.653 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 43 | 0.634 | |
| phospholipase c activating g protein coupled receptor signaling pathway | GO:0007200 | 15 | 0.624 | |
| cgmp metabolic process | GO:0046068 | 19 | 0.571 | |
| negative regulation of cyclic nucleotide biosynthetic process | GO:0030803 | 10 | 0.556 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 3 | 0.542 | |
| trivalent inorganic anion homeostasis | GO:0072506 | 7 | 0.529 | |
| negative regulation of sodium ion transport | GO:0010766 | 3 | 0.489 | |
| adenylate cyclase inhibiting serotonin receptor signaling pathway | GO:0007198 | 2 | 0.481 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.479 | |
| bicarbonate transport | GO:0015701 | 6 | 0.476 | |
| microvillus organization | GO:0032528 | 2 | 0.467 | |
| negative regulation of insulin secretion involved in cellular response to glucose stimulus | GO:0061179 | 1 | 0.459 | |
| positive regulation of phosphatidylinositol biosynthetic process | GO:0010513 | 3 | 0.449 | |
| cellular ion homeostasis | GO:0006873 | 168 | 0.446 | |
| negative regulation of purine nucleotide biosynthetic process | GO:1900372 | 11 | 0.443 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.442 | |
| regulation of cyclic nucleotide biosynthetic process | GO:0030802 | 49 | 0.401 | |
| ribonucleotide biosynthetic process | GO:0009260 | 81 | 0.395 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.391 | |
| negative regulation of lyase activity | GO:0051350 | 7 | 0.379 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 207 | 0.374 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.374 | |
| negative regulation of nucleotide biosynthetic process | GO:0030809 | 11 | 0.362 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.356 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 79 | 0.335 | |
| cellular trivalent inorganic anion homeostasis | GO:0072502 | 4 | 0.334 | |
| amine metabolic process | GO:0009308 | 44 | 0.315 | |
| purine nucleotide biosynthetic process | GO:0006164 | 84 | 0.299 | |
| negative regulation of cyclic nucleotide metabolic process | GO:0030800 | 10 | 0.298 | |
| cellular monovalent inorganic anion homeostasis | GO:0030320 | 4 | 0.278 | |
| positive regulation of vasodilation | GO:0045909 | 4 | 0.273 | |
| inorganic anion transmembrane transport | GO:0098661 | 47 | 0.269 | |
| sodium ion transport | GO:0006814 | 61 | 0.269 | |
| negative regulation of cyclase activity | GO:0031280 | 6 | 0.269 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.265 | |
| cellular divalent inorganic anion homeostasis | GO:0072501 | 4 | 0.261 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.257 | |
| negative regulation of sodium ion transmembrane transporter activity | GO:2000650 | 2 | 0.255 | |
| mitotic sister chromatid separation | GO:0051306 | 18 | 0.240 | |
| anterior posterior axis specification | GO:0009948 | 2 | 0.232 | |
| cyclic nucleotide mediated signaling | GO:0019935 | 26 | 0.230 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.229 | Human |
| phosphate ion homeostasis | GO:0055062 | 7 | 0.229 | |
| purine containing compound biosynthetic process | GO:0072522 | 88 | 0.227 | |
| regulation of lyase activity | GO:0051339 | 23 | 0.224 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 99 | 0.223 | |
| chromosome separation | GO:0051304 | 23 | 0.222 | |
| organic anion transport | GO:0015711 | 103 | 0.222 | |
| female gamete generation | GO:0007292 | 2 | 0.222 | |
| ion homeostasis | GO:0050801 | 230 | 0.220 | |
| membrane hyperpolarization | GO:0060081 | 1 | 0.219 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.216 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.214 | Human |
| regulation of sodium proton antiporter activity | GO:0032415 | 3 | 0.214 | |
| divalent inorganic anion homeostasis | GO:0072505 | 8 | 0.211 | |
| positive regulation of ion transmembrane transport | GO:0034767 | 40 | 0.201 | |
| renal system process | GO:0003014 | 25 | 0.201 | |
| regulation of cell cell adhesion | GO:0022407 | 57 | 0.200 | |
| negative regulation of protein kinase b signaling | GO:0051898 | 17 | 0.200 | |
| regulation of tyrosine phosphorylation of stat3 protein | GO:0042516 | 18 | 0.199 | |
| organic hydroxy compound transport | GO:0015850 | 63 | 0.198 | |
| cation homeostasis | GO:0055080 | 189 | 0.197 | |
| alcohol metabolic process | GO:0006066 | 114 | 0.196 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.195 | |
| positive regulation of ion transport | GO:0043270 | 87 | 0.194 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 109 | 0.189 | |
| cellular anion homeostasis | GO:0030002 | 4 | 0.189 | |
| plasma membrane organization | GO:0007009 | 115 | 0.188 | |
| cellular chemical homeostasis | GO:0055082 | 180 | 0.187 | |
| regulation of purine nucleotide biosynthetic process | GO:1900371 | 50 | 0.187 | |
| negative regulation of tyrosine phosphorylation of stat3 protein | GO:0042518 | 2 | 0.183 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.182 | Human |
| negative regulation of ion transmembrane transport | GO:0034766 | 26 | 0.181 | |
| cellular metal ion homeostasis | GO:0006875 | 146 | 0.179 | |
| regulation of cgmp biosynthetic process | GO:0030826 | 4 | 0.178 | |
| nucleotide biosynthetic process | GO:0009165 | 109 | 0.175 | |
| single organism membrane organization | GO:0044802 | 268 | 0.169 | |
| hippo signaling | GO:0035329 | 20 | 0.165 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.162 | |
| oocyte differentiation | GO:0009994 | 2 | 0.161 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.157 | |
| protein catabolic process | GO:0030163 | 325 | 0.157 | |
| regulation of cell motility | GO:2000145 | 299 | 0.152 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.151 | Human |
| cellular cation homeostasis | GO:0030003 | 163 | 0.150 | |
| regulation of ion transport | GO:0043269 | 189 | 0.146 | |
| camp mediated signaling | GO:0019933 | 23 | 0.146 | |
| lipid transport | GO:0006869 | 90 | 0.144 | |
| regulation of transmembrane transporter activity | GO:0022898 | 74 | 0.143 | |
| membrane organization | GO:0061024 | 292 | 0.143 | |
| metal ion homeostasis | GO:0055065 | 169 | 0.142 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.141 | |
| glycerolipid metabolic process | GO:0046486 | 107 | 0.140 | |
| positive regulation of transmembrane transport | GO:0034764 | 41 | 0.139 | |
| sensory perception of pain | GO:0019233 | 4 | 0.138 | |
| secretion | GO:0046903 | 254 | 0.137 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 55 | 0.136 | |
| actin cytoskeleton organization | GO:0030036 | 207 | 0.135 | |
| regulation of cell migration | GO:0030334 | 289 | 0.134 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.133 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.132 | Human |
| positive regulation of transport | GO:0051050 | 336 | 0.131 | |
| anterior posterior axis specification embryo | GO:0008595 | 2 | 0.131 | |
| regulation of locomotion | GO:0040012 | 329 | 0.130 | |
| establishment or maintenance of epithelial cell apical basal polarity | GO:0045197 | 1 | 0.129 | |
| amino acid transport | GO:0006865 | 28 | 0.129 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.128 | Human |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.128 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.126 | Human |
| negative regulation of purine nucleotide metabolic process | GO:1900543 | 28 | 0.126 | |
| negative regulation of jak stat cascade | GO:0046426 | 4 | 0.126 | |
| single organism cellular localization | GO:1902580 | 332 | 0.125 | |
| blastoderm segmentation | GO:0007350 | 2 | 0.123 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 37 | 0.123 | |
| regulation of mitosis | GO:0007088 | 63 | 0.123 | |
| inorganic ion transmembrane transport | GO:0098660 | 231 | 0.122 | |
| sodium ion transmembrane transport | GO:0035725 | 59 | 0.121 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.121 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.120 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.118 | |
| regulation of vasodilation | GO:0042312 | 4 | 0.118 | |
| anaphase promoting complex dependent proteasomal ubiquitin dependent protein catabolic process | GO:0031145 | 25 | 0.117 | |
| regulation of blood vessel size | GO:0050880 | 18 | 0.116 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.115 | Human |
| vasodilation | GO:0042311 | 4 | 0.114 | |
| regulation of secretion | GO:0051046 | 194 | 0.112 | |
| negative regulation of locomotion | GO:0040013 | 118 | 0.110 | |
| mapk cascade | GO:0000165 | 288 | 0.109 | |
| chemical homeostasis | GO:0048878 | 306 | 0.109 | |
| lipid localization | GO:0010876 | 106 | 0.108 | |
| cell morphogenesis | GO:0000902 | 296 | 0.106 | |
| adenylate cyclase inhibiting g protein coupled receptor signaling pathway | GO:0007193 | 22 | 0.105 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.105 | |
| sensory perception | GO:0007600 | 103 | 0.105 | |
| anion transport | GO:0006820 | 161 | 0.104 | |
| epithelial cell development | GO:0002064 | 34 | 0.103 | |
| monovalent inorganic anion homeostasis | GO:0055083 | 8 | 0.103 | |
| regulation of phosphatidylinositol 3 kinase signaling | GO:0014066 | 35 | 0.102 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 175 | 0.101 | |
| negative regulation of transport | GO:0051051 | 176 | 0.101 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.099 | Human |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.098 | |
| second messenger mediated signaling | GO:0019932 | 78 | 0.098 | |
| cell activation | GO:0001775 | 213 | 0.098 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.098 | |
| negative regulation of nucleotide metabolic process | GO:0045980 | 29 | 0.097 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.096 | Human |
| cell adhesion | GO:0007155 | 325 | 0.096 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.096 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.091 | |
| negative regulation of cell migration | GO:0030336 | 102 | 0.090 | |
| actin filament based process | GO:0030029 | 224 | 0.090 | |
| regulation of lymphocyte migration | GO:2000401 | 22 | 0.089 | |
| cellular homeostasis | GO:0019725 | 196 | 0.088 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.088 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.085 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.085 | Human |
| proteasomal protein catabolic process | GO:0010498 | 176 | 0.084 | |
| inositol lipid mediated signaling | GO:0048017 | 55 | 0.084 | |
| negative regulation of secretion | GO:0051048 | 58 | 0.084 | |
| carboxylic acid transport | GO:0046942 | 63 | 0.084 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.084 | Human |
| positive regulation of gtpase activity | GO:0043547 | 166 | 0.083 | Human |
| microvillus assembly | GO:0030033 | 2 | 0.083 | |
| cell projection assembly | GO:0030031 | 126 | 0.083 | |
| dna replication | GO:0006260 | 116 | 0.082 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.082 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 156 | 0.081 | |
| regulation of chromosome segregation | GO:0051983 | 44 | 0.080 | |
| skin development | GO:0043588 | 76 | 0.080 | |
| negative regulation of dna replication | GO:0008156 | 29 | 0.079 | |
| regulation of cytoskeleton organization | GO:0051493 | 177 | 0.079 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.079 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.079 | Human |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 75 | 0.078 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 186 | 0.078 | Human |
| nuclear division | GO:0000280 | 128 | 0.078 | |
| myosin filament assembly | GO:0031034 | 2 | 0.077 | |
| metaphase anaphase transition of cell cycle | GO:0044784 | 21 | 0.077 | |
| regulation of system process | GO:0044057 | 101 | 0.076 | |
| organic hydroxy compound metabolic process | GO:1901615 | 147 | 0.076 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.076 | |
| regulation of camp metabolic process | GO:0030814 | 52 | 0.075 | |
| modification dependent protein catabolic process | GO:0019941 | 209 | 0.075 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.075 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.074 | Human |
| vascular process in circulatory system | GO:0003018 | 29 | 0.074 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.074 | |
| post embryonic development | GO:0009791 | 2 | 0.074 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.073 | |
| regulation of cell activation | GO:0050865 | 125 | 0.073 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.072 | Human |
| single organismal cell cell adhesion | GO:0016337 | 148 | 0.072 | |
| locomotory behavior | GO:0007626 | 1 | 0.072 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.071 | |
| positive regulation of secretion by cell | GO:1903532 | 108 | 0.071 | |
| regulation of mapk cascade | GO:0043408 | 262 | 0.071 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 181 | 0.070 | |
| peptide transport | GO:0015833 | 74 | 0.070 | |
| nervous system development | GO:0007399 | 293 | 0.069 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.068 | |
| desensitization of g protein coupled receptor protein signaling pathway by arrestin | GO:0002032 | 2 | 0.068 | |
| cation transport | GO:0006812 | 331 | 0.068 | |
| hormone secretion | GO:0046879 | 65 | 0.068 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 185 | 0.068 | Human |
| regeneration | GO:0031099 | 4 | 0.068 | |
| taxis | GO:0042330 | 157 | 0.067 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 159 | 0.067 | |
| negative regulation of transmembrane transport | GO:0034763 | 29 | 0.067 | |
| serotonin receptor signaling pathway | GO:0007210 | 11 | 0.067 | |
| ion transmembrane transport | GO:0034220 | 338 | 0.066 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 38 | 0.066 | |
| regulation of cell division | GO:0051302 | 116 | 0.065 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.065 | Fly |
| positive regulation of ras gtpase activity | GO:0032320 | 117 | 0.063 | Human |
| regulation of transferase activity | GO:0051338 | 355 | 0.062 | |
| ameboidal type cell migration | GO:0001667 | 135 | 0.062 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 200 | 0.062 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 108 | 0.061 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 73 | 0.061 | |
| metal ion transport | GO:0030001 | 272 | 0.061 | |
| chloride transmembrane transport | GO:1902476 | 38 | 0.061 | |
| regulation of ion transmembrane transport | GO:0034765 | 132 | 0.061 | |
| organophosphate biosynthetic process | GO:0090407 | 163 | 0.061 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 127 | 0.061 | |
| negative regulation of secretion by cell | GO:1903531 | 52 | 0.061 | |
| monovalent inorganic cation transport | GO:0015672 | 128 | 0.060 | |
| regulation of platelet derived growth factor receptor signaling pathway | GO:0010640 | 6 | 0.060 | |
| neurogenesis | GO:0022008 | 169 | 0.060 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.059 | |
| transmembrane transport | GO:0055085 | 399 | 0.059 | |
| hormone transport | GO:0009914 | 68 | 0.059 | |
| inorganic cation transmembrane transport | GO:0098662 | 194 | 0.059 | |
| cellular response to organic cyclic compound | GO:0071407 | 127 | 0.059 | |
| regulation of cell adhesion | GO:0030155 | 166 | 0.059 | |
| regulation of gtpase activity | GO:0043087 | 180 | 0.058 | Human |
| cytoplasmic transport | GO:0016482 | 379 | 0.058 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 71 | 0.058 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.058 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.057 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.057 | |
| epithelium development | GO:0060429 | 227 | 0.057 | Fly |
| negative regulation of tyrosine phosphorylation of stat protein | GO:0042532 | 2 | 0.057 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.057 | |
| protein targeting | GO:0006605 | 187 | 0.057 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.057 | Human |
| oogenesis | GO:0048477 | 2 | 0.056 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.056 | Human |
| hydrogen transport | GO:0006818 | 23 | 0.056 | |
| negative regulation of platelet aggregation | GO:0090331 | 3 | 0.056 | |
| sequestering of metal ion | GO:0051238 | 24 | 0.055 | |
| segmentation | GO:0035282 | 4 | 0.055 | |
| potassium ion transport | GO:0006813 | 62 | 0.054 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 70 | 0.053 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 72 | 0.053 | |
| cell development | GO:0048468 | 328 | 0.053 | |
| regulation of ras protein signal transduction | GO:0046578 | 155 | 0.053 | Human |
| regulation of calcium ion transport | GO:0051924 | 79 | 0.052 | |
| glycerophospholipid metabolic process | GO:0006650 | 84 | 0.052 | |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.052 | Human |
| cell cycle phase transition | GO:0044770 | 173 | 0.052 | |
| calcium ion transport | GO:0006816 | 147 | 0.052 | |
| single organism cell adhesion | GO:0098602 | 179 | 0.052 | |
| regulation of dna metabolic process | GO:0051052 | 153 | 0.052 | |
| oocyte development | GO:0048599 | 1 | 0.051 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.051 | Human |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.051 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 128 | 0.050 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 191 | 0.050 | |
| erk1 and erk2 cascade | GO:0070371 | 104 | 0.050 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.050 | |
| tube morphogenesis | GO:0035239 | 95 | 0.049 | Fly |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.049 | |
| chloride transport | GO:0006821 | 41 | 0.049 | |
| regulation of metal ion transport | GO:0010959 | 120 | 0.049 | |
| blood vessel development | GO:0001568 | 172 | 0.049 | |
| protein localization to membrane | GO:0072657 | 160 | 0.049 | |
| regulation of mitotic sister chromatid segregation | GO:0033047 | 27 | 0.048 | |
| gastro intestinal system smooth muscle contraction | GO:0014831 | 2 | 0.048 | |
| endomembrane system organization | GO:0010256 | 196 | 0.048 | |
| regulation of mitotic sister chromatid separation | GO:0010965 | 27 | 0.048 | |
| regulation of tube size | GO:0035150 | 18 | 0.048 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 205 | 0.048 | Human |
| activation of mapk activity | GO:0000187 | 45 | 0.048 | |
| regulation of sister chromatid segregation | GO:0033045 | 27 | 0.047 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 187 | 0.047 | |
| cgmp biosynthetic process | GO:0006182 | 12 | 0.047 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.047 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.047 | |
| regulation of chromosome organization | GO:0033044 | 103 | 0.046 | |
| organelle assembly | GO:0070925 | 176 | 0.046 | |
| negative regulation of cellular component movement | GO:0051271 | 106 | 0.046 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.046 | Human |
| negative regulation of cell motility | GO:2000146 | 104 | 0.046 | |
| guanosine containing compound catabolic process | GO:1901069 | 239 | 0.046 | Human |
| jak stat cascade | GO:0007259 | 46 | 0.046 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 206 | 0.046 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.046 | |
| lipid metabolic process | GO:0006629 | 381 | 0.045 | |
| regulation of leukocyte activation | GO:0002694 | 115 | 0.045 | |
| proton transport | GO:0015992 | 22 | 0.045 | |
| positive regulation of biomineral tissue development | GO:0070169 | 20 | 0.045 | |
| associative learning | GO:0008306 | 1 | 0.045 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.045 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.044 | |
| intestine smooth muscle contraction | GO:0014827 | 2 | 0.044 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 1 | 0.044 | |
| amide transport | GO:0042886 | 76 | 0.043 | |
| tripartite regional subdivision | GO:0007351 | 2 | 0.043 | |
| epidermal cell differentiation | GO:0009913 | 45 | 0.043 | |
| gastrulation | GO:0007369 | 51 | 0.042 | |
| divalent metal ion transport | GO:0070838 | 152 | 0.042 | |
| adenylate cyclase inhibiting adrenergic receptor signaling pathway | GO:0071881 | 1 | 0.042 | |
| lipid catabolic process | GO:0016042 | 84 | 0.042 | |
| tyrosine phosphorylation of stat3 protein | GO:0042503 | 20 | 0.042 | |
| neuron differentiation | GO:0030182 | 138 | 0.042 | |
| positive regulation of cytokine production | GO:0001819 | 167 | 0.042 | |
| negative regulation of peptidyl tyrosine phosphorylation | GO:0050732 | 20 | 0.042 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.042 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.042 | |
| response to lipid | GO:0033993 | 206 | 0.041 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 158 | 0.041 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 186 | 0.041 | |
| divalent inorganic cation homeostasis | GO:0072507 | 136 | 0.041 | |
| inorganic anion transport | GO:0015698 | 60 | 0.041 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.041 | Human |
| cyclic nucleotide metabolic process | GO:0009187 | 82 | 0.041 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.041 | Human |
| small molecule biosynthetic process | GO:0044283 | 157 | 0.040 | |
| epidermal growth factor activated receptor transactivation by g protein coupled receptor signaling pathway | GO:0035625 | 4 | 0.040 | |
| actin filament organization | GO:0007015 | 128 | 0.040 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 186 | 0.040 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 6 | 0.040 | |
| divalent inorganic cation transport | GO:0072511 | 158 | 0.039 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.039 | Human |
| tube development | GO:0035295 | 125 | 0.039 | Fly |
| metaphase anaphase transition of mitotic cell cycle | GO:0007091 | 21 | 0.039 | |
| acid secretion | GO:0046717 | 12 | 0.039 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.039 | |
| cell projection organization | GO:0030030 | 252 | 0.039 | |
| organelle fission | GO:0048285 | 149 | 0.038 | |
| regulation of dna replication | GO:0006275 | 68 | 0.038 | |
| cellular response to nitrogen compound | GO:1901699 | 144 | 0.038 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.038 | |
| negative regulation of homotypic cell cell adhesion | GO:0034111 | 3 | 0.038 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.038 | Human |
| regulation of nucleoside metabolic process | GO:0009118 | 209 | 0.038 | Human |
| myosin filament organization | GO:0031033 | 2 | 0.037 | |
| regulation of transmembrane transport | GO:0034762 | 139 | 0.037 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.037 | |
| spermatid development | GO:0007286 | 4 | 0.037 | |
| regulation of sodium ion transmembrane transport | GO:1902305 | 23 | 0.036 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.036 | |
| digestive system development | GO:0055123 | 75 | 0.036 | |
| regulation of transporter activity | GO:0032409 | 82 | 0.036 | |
| copulation | GO:0007620 | 1 | 0.036 | |
| cell cell signaling | GO:0007267 | 155 | 0.036 | |
| maintenance of location | GO:0051235 | 112 | 0.036 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.035 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.035 | |
| organic acid transport | GO:0015849 | 65 | 0.035 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 170 | 0.035 | |
| positive regulation of synaptic transmission | GO:0050806 | 4 | 0.035 | |
| sensory perception of sound | GO:0007605 | 37 | 0.035 | |
| secretion by cell | GO:0032940 | 226 | 0.035 | |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.035 | |
| stress fiber assembly | GO:0043149 | 40 | 0.035 | |
| immune response | GO:0006955 | 307 | 0.035 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 2 | 0.035 | |
| digestive tract morphogenesis | GO:0048546 | 56 | 0.034 | |
| protein maturation | GO:0051604 | 233 | 0.034 | |
| regulation of binding | GO:0051098 | 111 | 0.034 | |
| circadian behavior | GO:0048512 | 2 | 0.033 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 72 | 0.033 | |
| cation transmembrane transport | GO:0098655 | 238 | 0.033 | |
| endothelial cell development | GO:0001885 | 18 | 0.033 | |
| phospholipid metabolic process | GO:0006644 | 99 | 0.033 | |
| signal release | GO:0023061 | 70 | 0.033 | |
| glial cell migration | GO:0008347 | 4 | 0.033 | |
| regulation of chemotaxis | GO:0050920 | 74 | 0.032 | |
| guanosine containing compound metabolic process | GO:1901068 | 244 | 0.032 | Human |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.032 | |
| regulation of chloride transport | GO:2001225 | 2 | 0.032 | |
| regulation of lipid biosynthetic process | GO:0046890 | 47 | 0.032 | |
| gtp catabolic process | GO:0006184 | 237 | 0.032 | Human |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.032 | |
| positive regulation of lipase activity | GO:0060193 | 28 | 0.032 | |
| atp metabolic process | GO:0046034 | 176 | 0.032 | |
| aging | GO:0007568 | 66 | 0.032 | |
| positive regulation of intracellular transport | GO:0032388 | 104 | 0.032 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.032 | Human |
| phosphatidylinositol 3 kinase signaling | GO:0014065 | 48 | 0.031 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 85 | 0.031 | |
| positive regulation of cellular component movement | GO:0051272 | 181 | 0.031 | |
| regulation of sodium ion transmembrane transporter activity | GO:2000649 | 17 | 0.031 | |
| regulation of proton transport | GO:0010155 | 3 | 0.031 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.031 | Human |
| regulation of lymphocyte activation | GO:0051249 | 103 | 0.031 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.031 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.030 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.030 | Human |
| regulation of protein catabolic process | GO:0042176 | 155 | 0.030 | |
| startle response | GO:0001964 | 3 | 0.030 | |
| response to cytokine | GO:0034097 | 232 | 0.030 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 4 | 0.029 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.029 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 158 | 0.029 | |
| mating | GO:0007618 | 1 | 0.029 | |
| regulation of secretion by cell | GO:1903530 | 177 | 0.029 | |
| cellular macromolecular complex assembly | GO:0034622 | 324 | 0.029 | |
| negative regulation of phagocytosis | GO:0050765 | 4 | 0.029 | |
| regulation of stress fiber assembly | GO:0051492 | 32 | 0.029 | |
| endothelial cell differentiation | GO:0045446 | 26 | 0.029 | |
| generation of neurons | GO:0048699 | 152 | 0.029 | |
| cellular protein catabolic process | GO:0044257 | 261 | 0.029 | |
| positive regulation of camp biosynthetic process | GO:0030819 | 35 | 0.028 | |
| growth | GO:0040007 | 202 | 0.028 | |
| vasculature development | GO:0001944 | 181 | 0.028 | |
| negative regulation of transporter activity | GO:0032410 | 25 | 0.028 | |
| cellular protein complex assembly | GO:0043623 | 188 | 0.028 | |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.028 | |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.028 | |
| central nervous system neuron axonogenesis | GO:0021955 | 3 | 0.028 | |
| cell migration involved in gastrulation | GO:0042074 | 1 | 0.028 | |
| protein localization to plasma membrane | GO:0072659 | 93 | 0.027 | |
| positive regulation of camp metabolic process | GO:0030816 | 41 | 0.027 | |
| negative regulation of axonogenesis | GO:0050771 | 4 | 0.027 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.027 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.027 | |
| defense response | GO:0006952 | 315 | 0.027 | |
| negative regulation of ion transmembrane transporter activity | GO:0032413 | 19 | 0.027 | |
| establishment of organelle localization | GO:0051656 | 59 | 0.027 | |
| regulation of lipid catabolic process | GO:0050994 | 23 | 0.027 | |
| melanin metabolic process | GO:0006582 | 1 | 0.027 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.026 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 3 | 0.026 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 212 | 0.026 | |
| actin filament bundle organization | GO:0061572 | 54 | 0.026 | |
| memory | GO:0007613 | 3 | 0.026 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.026 | |
| positive regulation of secretion | GO:0051047 | 116 | 0.026 | |
| cell projection morphogenesis | GO:0048858 | 129 | 0.025 | |
| behavior | GO:0007610 | 112 | 0.025 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 244 | 0.025 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.025 | |
| regulation of vasculature development | GO:1901342 | 97 | 0.025 | |
| negative regulation of muscle contraction | GO:0045932 | 3 | 0.025 | |
| endothelium development | GO:0003158 | 33 | 0.025 | |
| response to external biotic stimulus | GO:0043207 | 261 | 0.025 | |
| oxidation reduction process | GO:0055114 | 396 | 0.025 | |
| ossification | GO:0001503 | 121 | 0.025 | |
| lymphocyte activation | GO:0046649 | 133 | 0.024 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.024 | |
| membrane to membrane docking | GO:0022614 | 5 | 0.024 | |
| quaternary ammonium group transport | GO:0015697 | 5 | 0.024 | |
| skeletal muscle tissue growth | GO:0048630 | 2 | 0.024 | |
| angiogenesis | GO:0001525 | 147 | 0.024 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.023 | |
| anion homeostasis | GO:0055081 | 18 | 0.023 | |
| muscle structure development | GO:0061061 | 98 | 0.023 | |
| regulation of hippo signaling | GO:0035330 | 8 | 0.023 | |
| regulation of membrane potential | GO:0042391 | 95 | 0.023 | |
| endocytosis | GO:0006897 | 159 | 0.023 | |
| presynaptic membrane organization | GO:0097090 | 3 | 0.023 | |
| regulation of protein processing | GO:0070613 | 150 | 0.023 | |
| positive regulation of locomotion | GO:0040017 | 186 | 0.023 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.023 | |
| regulation of cytoplasmic transport | GO:1903649 | 149 | 0.023 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.023 | |
